0.0175
+0.0037
+(26.81%)
At close: January 28 at 3:51:22 PM EST
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Nicholas Peter Karos | CEO, Director of Capital Markets & Director | 166.63k | -- | -- |
| Mr. Greg J. Leavens C.A., CPA | CFO & Corporate Secretary | 121.5k | -- | 1965 |
| Mr. Shayne Nyquvest | Co-Founder | 160.44k | -- | -- |
| Cathy Fernandes | VP of Marketing & VP of Communications | -- | -- | -- |
Universal Ibogaine Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. It undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. The company is headquartered in Calgary, Canada.
Corporate Governance
Universal Ibogaine Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
RBSH Rebus Holdings, Inc.
0.0001
0.00%
ZHCLF Zenith Capital Corp.
0.0001
0.00%
BETRF BetterLife Pharma Inc.
0.0915
-23.75%
WSNAF Wesana Health Holdings Inc.
0.1050
+66.67%
IBO Impact BioMedical Inc.
1.7000
-5.03%
MDMA.CN Pharmala Biotech Holdings Inc.
0.2000
-11.11%
TARS Tarsus Pharmaceuticals, Inc.
51.06
-0.76%
RNA Avidity Biosciences, Inc.
32.08
+5.39%
CRDF Cardiff Oncology, Inc.
3.4200
+0.29%
MNMD Mind Medicine (MindMed) Inc.
7.43
+7.68%